Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-05-25 Purchase |
2023-05-30 4:21 pm |
PIERIS PHARMACEUTICALS INC. | PIRS | KIRITSY CHRISTOPHER P Director |
10,000 | $0.85 | $8,500 | 20,000 (Direct) |
View |
2022-05-13 Purchase |
2022-05-16 8:19 pm |
PIERIS PHARMACEUTICALS INC. | PIRS | Demuth Tim Chief Medical Officer |
6,000 | $1.71 | $10,260 | 6,000 (Direct) |
View |
2021-08-30 Sale |
2021-09-01 4:38 pm |
PIERIS PHARMACEUTICALS INC. | PIRS | Olwill Shane Chief Development Officer |
38,400 | $5.1141 | $196,380 | 66,238 (Direct) |
View |
2020-07-21 Sale |
2020-07-22 6:15 pm |
PIERIS PHARMACEUTICALS INC. | PIRS | Aquilo Capital Management LLC 10% Owner |
1,900,000 | $2.95 | $5,605,000 | 3,675,530 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-06-21 Option Award |
2023-06-23 4:45 pm |
N/A 2033-06-21 |
PIERIS PHARMACEUTICALS INC. | PIRS | Richman Michael Director |
40,000 | $0 | 40,000 (Direct) |
View |
2023-06-21 Option Award |
2023-06-23 4:45 pm |
N/A 2033-06-21 |
PIERIS PHARMACEUTICALS INC. | PIRS | Said Maya R. Director |
40,000 | $0 | 40,000 (Direct) |
View |
2023-06-21 Option Award |
2023-06-23 4:45 pm |
N/A 2033-06-21 |
PIERIS PHARMACEUTICALS INC. | PIRS | Sherman Matthew L Director |
40,000 | $0 | 40,000 (Direct) |
View |
Ownership |
2023-05-22 5:00 pm |
N/A N/A |
PIERIS PHARMACEUTICALS INC. | PIRS | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
0 | $0 | 39,154,557 (Direct) |
View |
2023-02-24 Option Award |
2023-02-28 5:39 pm |
N/A 2033-02-24 |
PIERIS PHARMACEUTICALS INC. | PIRS | Bures Thomas Chief Financial Officer |
249,080 | $0 | 249,080 (Direct) |
View |
2023-02-24 Option Award |
2023-02-28 5:35 pm |
N/A 2033-02-24 |
PIERIS PHARMACEUTICALS INC. | PIRS | Kaufmann Hitto Chief Scientific Officer |
249,080 | $0 | 249,080 (Direct) |
View |
2023-02-24 Option Award |
2023-02-28 5:31 pm |
N/A 2033-02-24 |
PIERIS PHARMACEUTICALS INC. | PIRS | Mousa Ahmed Chief Business Officer |
249,080 | $0 | 249,080 (Direct) |
View |
2023-02-24 Option Award |
2023-02-28 5:23 pm |
N/A 2033-02-24 |
PIERIS PHARMACEUTICALS INC. | PIRS | Olwill Shane Chief Development Officer |
249,080 | $0 | 249,080 (Direct) |
View |
2023-02-24 Option Award |
2023-02-28 5:09 pm |
N/A 2033-02-24 |
PIERIS PHARMACEUTICALS INC. | PIRS | Yoder Stephen S. Chief Executive Officer |
634,021 | $0 | 634,021 (Direct) |
View |
2022-06-22 Option Award |
2022-06-24 7:04 pm |
N/A 2032-06-22 |
PIERIS PHARMACEUTICALS INC. | PIRS | Barbier Ann Director |
40,000 | $0 | 40,000 (Direct) |
View |
2022-06-22 Option Award |
2022-06-24 7:04 pm |
N/A 2032-06-22 |
PIERIS PHARMACEUTICALS INC. | PIRS | Said Maya R. Director |
40,000 | $0 | 40,000 (Direct) |
View |
2022-06-22 Option Award |
2022-06-24 7:03 pm |
N/A 2032-06-22 |
PIERIS PHARMACEUTICALS INC. | PIRS | GERAGHTY JAMES A Director |
45,000 | $0 | 45,000 (Direct) |
View |
2022-06-22 Option Award |
2022-06-24 7:03 pm |
N/A 2032-06-22 |
PIERIS PHARMACEUTICALS INC. | PIRS | Kiener Peter A Director |
40,000 | $0 | 40,000 (Direct) |
View |
2022-06-22 Option Award |
2022-06-24 7:03 pm |
N/A 2032-06-22 |
PIERIS PHARMACEUTICALS INC. | PIRS | KIRITSY CHRISTOPHER P Director |
40,000 | $0 | 40,000 (Direct) |
View |
2022-06-22 Option Award |
2022-06-24 7:02 pm |
N/A 2032-06-22 |
PIERIS PHARMACEUTICALS INC. | PIRS | Richman Michael Director |
40,000 | $0 | 40,000 (Direct) |
View |
2022-06-22 Option Award |
2022-06-24 7:02 pm |
N/A 2032-06-22 |
PIERIS PHARMACEUTICALS INC. | PIRS | Sherman Matthew L Director |
40,000 | $0 | 40,000 (Direct) |
View |
2022-02-22 Option Award |
2022-02-24 4:50 pm |
N/A 2032-02-22 |
PIERIS PHARMACEUTICALS INC. | PIRS | Demuth Tim Chief Medical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
2022-02-22 Option Award |
2022-02-24 4:48 pm |
N/A 2032-02-22 |
PIERIS PHARMACEUTICALS INC. | PIRS | Mousa Ahmed Chief Business Officer |
215,819 | $0 | 215,819 (Direct) |
View |
2022-02-22 Option Award |
2022-02-24 4:47 pm |
N/A 2032-02-22 |
PIERIS PHARMACEUTICALS INC. | PIRS | Olwill Shane Chief Development Officer |
215,819 | $0 | 215,819 (Direct) |
View |
2022-02-22 Option Award |
2022-02-24 4:46 pm |
N/A 2032-02-22 |
PIERIS PHARMACEUTICALS INC. | PIRS | Bures Thomas Chief Financial Officer |
215,819 | $0 | 215,819 (Direct) |
View |
2022-02-22 Option Award |
2022-02-24 4:45 pm |
N/A 2032-02-22 |
PIERIS PHARMACEUTICALS INC. | PIRS | Kaufmann Hitto SVP, Chief Scientific Officer |
215,819 | $0 | 215,819 (Direct) |
View |
2022-02-22 Option Award |
2022-02-24 4:44 pm |
N/A 2032-02-22 |
PIERIS PHARMACEUTICALS INC. | PIRS | Yoder Stephen S. Chief Executive Officer |
625,874 | $0 | 625,874 (Direct) |
View |
Ownership |
2021-10-21 5:08 pm |
N/A 2026-01-21 |
PIERIS PHARMACEUTICALS INC. | PIRS | Mousa Ahmed Chief Business Officer |
0 | $0 | 545,000 (Direct) |
View |
2021-08-30 Exercise |
2021-09-01 4:38 pm |
N/A N/A |
PIERIS PHARMACEUTICALS INC. | PIRS | Olwill Shane Chief Development Officer |
38,400 | $1.52 | 66,238 (Direct) |
View |
2021-08-30 Exercise |
2021-09-01 4:38 pm |
N/A 2026-02-12 |
PIERIS PHARMACEUTICALS INC. | PIRS | Olwill Shane Chief Development Officer |
38,400 | $0 | 66,238 (Direct) |
View |
2021-08-01 Option Award |
2021-08-03 4:19 pm |
N/A 2031-08-01 |
PIERIS PHARMACEUTICALS INC. | PIRS | Demuth Tim Chief Medical Officer |
360,000 | $0 | 360,000 (Direct) |
View |
Ownership |
2021-08-03 4:09 pm |
N/A N/A |
PIERIS PHARMACEUTICALS INC. | PIRS | Olwill Shane Chief Development Officer |
0 | $0 | 717,888 (Direct) |
View |
2021-06-25 Option Award |
2021-06-29 5:38 pm |
N/A 2031-06-25 |
PIERIS PHARMACEUTICALS INC. | PIRS | Sherman Matthew L Director |
40,000 | $0 | 40,000 (Direct) |
View |
2021-06-25 Option Award |
2021-06-29 5:36 pm |
N/A 2031-06-25 |
PIERIS PHARMACEUTICALS INC. | PIRS | Said Maya R. Director |
40,000 | $0 | 40,000 (Direct) |
View |
2021-06-25 Option Award |
2021-06-29 5:33 pm |
N/A 2031-06-25 |
PIERIS PHARMACEUTICALS INC. | PIRS | Richman Michael Director |
40,000 | $0 | 40,000 (Direct) |
View |
2021-06-25 Option Award |
2021-06-29 5:30 pm |
N/A 2031-06-25 |
PIERIS PHARMACEUTICALS INC. | PIRS | KIRITSY CHRISTOPHER P Director |
40,000 | $0 | 40,000 (Direct) |
View |
2021-06-25 Option Award |
2021-06-29 5:26 pm |
N/A 2031-06-25 |
PIERIS PHARMACEUTICALS INC. | PIRS | Kiener Peter A Director |
40,000 | $0 | 40,000 (Direct) |
View |
2021-06-25 Option Award |
2021-06-29 5:23 pm |
N/A 2031-06-25 |
PIERIS PHARMACEUTICALS INC. | PIRS | GERAGHTY JAMES A Director |
45,000 | $0 | 45,000 (Direct) |
View |
2021-06-25 Option Award |
2021-06-29 5:19 pm |
N/A 2031-06-25 |
PIERIS PHARMACEUTICALS INC. | PIRS | Barbier Ann Director |
40,000 | $0 | 40,000 (Direct) |
View |
2021-03-04 Option Award |
2021-03-08 4:08 pm |
N/A 2031-03-04 |
PIERIS PHARMACEUTICALS INC. | PIRS | Bures Thomas Vice President, Finance |
150,000 | $0 | 150,000 (Direct) |
View |
2021-03-04 Option Award |
2021-03-08 4:08 pm |
N/A 2031-03-04 |
PIERIS PHARMACEUTICALS INC. | PIRS | Kaufmann Hitto SVP, Chief Scientific Officer |
220,000 | $0 | 220,000 (Direct) |
View |
2021-03-04 Option Award |
2021-03-08 4:07 pm |
N/A 2031-03-04 |
PIERIS PHARMACEUTICALS INC. | PIRS | Yoder Stephen S. Chief Executive Officer |
530,000 | $0 | 530,000 (Direct) |
View |